Insys Therapeutics - 48 Year Dividend Yield History | INSY

Historical dividend payout and yield for Insys Therapeutics (INSY) since 1971. The current TTM dividend payout for Insys Therapeutics (INSY) as of February 22, 2019 is $0.00. The current dividend yield for Insys Therapeutics as of February 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.426B $0.141B
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
Phibro Animal Health (PAHC) United States $1.220B 17.53
Meridian Bioscience (VIVO) United States $0.733B 21.85
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Owens & Minor (OMI) United States $0.408B 5.65
Utah Medical Products (UTMD) United States $0.339B 21.99
United-Guardian (UG) United States $0.090B 18.77